Applied Nutrition (LSE:APN) Research & Development: £0.0 Mil (TTM As of Jan. 2026)


LSE:APN Applied Nutrition PLC LSE:APN
27 GF Score
Price £3.10
! 5 Warning Signs
View Full Analysis

What is Applied Nutrition Research & Development?

Applied Nutrition LSE:APN 27 Research & Development is £0.0 Mil as of Jan. 2026. GuruFocus rates LSE:APN with a GF Score™ of 27/100. The stock has 5 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Applied Nutrition's Research & Development for the six months ended in Jan. 2026 was £0.0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Jan. 2026 was £0.0 Mil.

Applied Nutrition  (LSE:APN) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Applied Nutrition Research & Development Related Terms

Applied Nutrition Research & Development Historical Data

* Premium members only.

The historical data trend for Applied Nutrition's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Applied Nutrition Research & Development Chart

Applied Nutrition Annual Data
Trend Jul22 Jul23 Jul24 Jul25
Research & Development
0.00 0.00 0.00 0.00

Applied Nutrition Semi-Annual Data
Jul22 Jul23 Jan24 Jul24 Jan25 Jul25 Jan26
Research & Development Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00
LSE:APN
27GF Score
Applied Nutrition PLC LSE:APN
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Applied Nutrition Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Jan. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was £0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of £0.0 Mil mean?
Applied Nutrition (LSE:APN) has a Research & Development of £0.0 Mil as of Jan. 2026. Research and development expense is the total cost for research and development activities. View historical data on Applied Nutrition and its competitors.
Is Applied Nutrition's Research & Development too high?
Applied Nutrition's current Research & Development is £0.0 Mil. Overall, Applied Nutrition has a GF Score™ of 27/100, reflecting its overall financial health beyond just this single metric.
How does Applied Nutrition's Research & Development compare to KHC and GIS?
Applied Nutrition's Research & Development of £0.0 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Consumer Packaged Goods company?
A good Research & Development depends on the Consumer Packaged Goods industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Applied Nutrition and its competitors. Applied Nutrition's current Research & Development is £0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Applied Nutrition stock overvalued right now?
Applied Nutrition (LSE:APN) has a current Research & Development of £0.0 Mil. The current Research & Development is £0.0 Mil. Applied Nutrition's overall GF Score™ is 27/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Applied Nutrition (LSE:APN), the current Research & Development is £0.0 Mil as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Applied Nutrition Business Description

Other Exchanges APNl:UK
Address 2 Trio, Acornfield Road, Knowsley Industrial Park, Liverpool, GBR, L33 7UG
Applied Nutrition PLC is a Sports and Active nutrition brand. It formulates and creates nutrition supplements for professional athletes, fitness enthusiasts, the gym lifestyle community, and people looking to supplement their diet with quality health, well-being, and beauty nutrition. Its products are Protein, Pre-workout, Clothing and Accessories, and others.
27GF Score

Get the complete analysis for LSE:APN

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

£3.10
Price